Loading...

Global Preventative Medicine Demand And mRNA Pipelines Will Transform Healthcare

Published
11 Apr 25
Updated
07 May 25
n/a
n/a
AnalystHighTarget's Fair Value
n/a
Loading
1Y
-32.8%
7D
0.9%

Author's Valuation

US$121.2779.6% undervalued intrinsic discount

AnalystHighTarget Fair Value

Shared on 07 May 25

Fair value Decreased 1.51%

Shared on 30 Apr 25

Fair value Decreased 3.15%

AnalystHighTarget made no meaningful changes to valuation assumptions.

Shared on 23 Apr 25

Fair value Increased 43%

AnalystHighTarget has increased future PE multiple from 84.2x to 120.1x.

Shared on 16 Apr 25

Fair value Decreased 0.66%

AnalystHighTarget made no meaningful changes to valuation assumptions.